These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36827075)
1. Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer. Wu Z; Zeng J; Wu M; Liang Q; Li B; Hou G; Lin Z; Xu W Medicine (Baltimore); 2023 Feb; 102(8):e33075. PubMed ID: 36827075 [TBL] [Abstract][Full Text] [Related]
2. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Lu H; Wu J; Liang L; Wang X; Cai H Front Immunol; 2022; 13():803355. PubMed ID: 35154117 [TBL] [Abstract][Full Text] [Related]
3. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer. Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227 [TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the endoplasmic reticulum stress-related long non-coding RNA in bladder cancer. Wu Z; Wang Y; Yan M; Liang Q; Li B; Hou G; Xia T; Lin Z; Xu W Front Oncol; 2022; 12():951631. PubMed ID: 35992824 [TBL] [Abstract][Full Text] [Related]
6. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977 [No Abstract] [Full Text] [Related]
7. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer. Lia T; Shao Y; Regmi P; Li X Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35024796 [TBL] [Abstract][Full Text] [Related]
9. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer. Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513 [TBL] [Abstract][Full Text] [Related]
10. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma. Zhang C; Li Z; Hu J; Qi F; Li X; Luo J J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406 [TBL] [Abstract][Full Text] [Related]
11. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
12. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer. Sun YF; Chen L; Xia QJ; Wang TH J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
14. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer. Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J Front Genet; 2022; 13():838624. PubMed ID: 35928454 [TBL] [Abstract][Full Text] [Related]
17. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer. Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610 [TBL] [Abstract][Full Text] [Related]
18. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer. Tong H; Li T; Gao S; Yin H; Cao H; He W Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830 [TBL] [Abstract][Full Text] [Related]
19. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540 [TBL] [Abstract][Full Text] [Related]
20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]